Gerry McGettigan is currently a Principal at Kinesys Consulting, a regulatory and technical advisory firm based in the U.K. Gerry, a molecular biologist, has twenty years’ experience in the biotechnology and pharmaceutical industries, in regulatory affairs, clinical development and business development. He has worked with large and medium pharma companies (Almirall and Glaxo) and was Regulatory & Scientific Affairs Director of cancer focused The Liposome Company, a US biotechnology firm. Gerry holds a BSc, B.A. and is a fellow of Topra.
pharmaceutical industry, Cancer Therapeutics